User profiles for James V. Alvarez

James Alvarez

Fred Hutchinson Cancer Research Center
Verified email at fredhutch.org
Cited by 2830

[HTML][HTML] Oncogenic transformation by inhibitor-sensitive and-resistant EGFR mutants

…, TH Chen, W Feng, PA Jänne, JV Alvarez… - PLoS …, 2005 - journals.plos.org
Background Somatic mutations in the kinase domain of the epidermal growth factor receptor
tyrosine kinase gene EGFR are common in lung adenocarcinoma. The presence of …

Signal transducer and activator of transcription 3 is required for the oncogenic effects of non–small-cell lung cancer–associated mutations of the epidermal growth …

JV Alvarez, H Greulich, WR Sellers, M Meyerson… - Cancer research, 2006 - AACR
Somatic mutations in the epidermal growth factor receptor (EGFR) occur frequently in lung
cancer and confer sensitivity to EGFR kinase inhibitors gefitinib and erlotinib. These mutations…

Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors

JV Alvarez, PG Febbo, S Ramaswamy, M Loda… - Cancer research, 2005 - AACR
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that is
activated in diverse human tumors and may play a direct role in malignant transformation. …

NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism

…, J Liu, JW Locasale, MD Hirschey, JV Alvarez - Nature …, 2020 - nature.com
The survival and recurrence of dormant tumour cells following therapy is a leading cause of
death in patients with cancer. The metabolic properties of these cells are likely to be distinct …

CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors

…, R Lupo, BR Kroger, JS Damrauer, JV Alvarez - Elife, 2019 - elifesciences.org
10.7554/eLife.43653.001 Over half of breast-cancer-related deaths are due to recurrence 5
or more years after initial diagnosis and treatment. This latency suggests that a population of …

[PDF][PDF] Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy

JV Alvarez, T Pan, J Ruth, Y Feng, A Zhou, D Pant… - Cancer cell, 2013 - cell.com
Most deaths from breast cancer result from tumor recurrence, but mechanisms underlying
tumor relapse are largely unknown. We now report that Par-4 is downregulated during tumor …

Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis

JV Alvarez, DA Frank - Cancer biology & therapy, 2004 - Taylor & Francis
Inappropriate activation of transcription factors is a common event in cancer. These transcription
factors contribute to a malignant phenotype by regulating genes involved in cellular …

Autocrine prolactin induced by the Pten–Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways

…, GK Belka, ND Horseman, JV Alvarez… - Genes & …, 2012 - genesdev.cshlp.org
Extrapituitary prolactin (Prl) is produced in humans and rodents; however, little is known
about its in vivo regulation or physiological function. We now report that autocrine prolactin is …

DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway

…, X Tang, PH Chen, CKC Ding, DC Qu, JV Alvarez… - Oncogene, 2021 - nature.com
Recurrent breast cancer presents significant challenges with aggressive phenotypes and
treatment resistance. Therefore, novel therapeutics are urgently needed. Here, we report that …

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

JV Alvarez, GK Belka, TC Pan, CC Chen… - Cancer research, 2014 - AACR
Increased glucose utilization is a hallmark of human cancer that is used to image tumors
clinically. In this widely used application, glucose uptake by tumors is monitored by positron …